TP53 |
P04637
|
tumor protein p53
|
Transcription factor
|
0.53 |
0.236 |
0.962 |
BCL2 |
P10415
|
BCL2 apoptosis regulator
|
Signaling
|
0.56 |
0.291 |
0.885 |
MMP9 |
P14780
|
matrix metallopeptidase 9
|
Enzyme
|
1.9E-17 |
0.305 |
0.923 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
KRAS |
P01116
|
KRAS proto-oncogene, GTPase
|
Enzyme modulator
|
7.9E-04 |
0.320 |
0.923 |
ESR1 |
P03372
|
estrogen receptor 1
|
Nuclear receptor
|
1.00 |
0.324 |
0.962 |
HIF1A |
Q16665
|
hypoxia inducible factor 1 subunit alpha
|
Transcription factor
|
0.98 |
0.327 |
0.923 |
AR |
P10275
|
androgen receptor
|
Nuclear receptor
|
0.99 |
0.351 |
0.846 |
FGFR1 |
P11362
|
fibroblast growth factor receptor 1
|
Kinase
|
1.00 |
0.362 |
0.885 |
PTPN11 |
Q06124
|
protein tyrosine phosphatase non-receptor type 11
|
|
1.00 |
0.385 |
0.923 |
NOTCH1 |
P46531
|
notch receptor 1
|
|
1.00 |
0.369 |
0.885 |
HGF |
P14210
|
hepatocyte growth factor
|
Enzyme
|
1.00 |
0.374 |
0.885 |
KDR |
P35968
|
kinase insert domain receptor
|
Kinase
|
1.00 |
0.378 |
0.885 |
MET |
P08581
|
MET proto-oncogene, receptor tyrosine kinase
|
Kinase
|
0.97 |
0.380 |
0.846 |
ESR2 |
Q92731
|
estrogen receptor 2
|
Nuclear receptor
|
4.5E-08 |
0.400 |
0.923 |
MMP3 |
P08254
|
matrix metallopeptidase 3
|
Enzyme
|
5.7E-15 |
0.408 |
0.885 |
BAX |
Q07812
|
BCL2 associated X, apoptosis regulator
|
Signaling
|
0.32 |
0.417 |
0.885 |
IDH1 |
O75874
|
isocitrate dehydrogenase (NADP(+)) 1
|
|
2.6E-12 |
0.424 |
0.808 |
NOTCH2 |
Q04721
|
notch receptor 2
|
|
1.00 |
0.441 |
0.808 |
NF1 |
P21359
|
neurofibromin 1
|
Enzyme modulator
|
0.90 |
0.440 |
0.885 |
IDH2 |
P48735
|
isocitrate dehydrogenase (NADP(+)) 2
|
|
0.88 |
0.434 |
0.808 |
NTRK2 |
Q16620
|
neurotrophic receptor tyrosine kinase 2
|
Kinase
|
1.00 |
0.479 |
0.808 |
LOC110806263 |
|
TERT 5' regulatory region
|
|
|
0.464 |
0.731 |
NDRG1 |
Q92597
|
N-myc downstream regulated 1
|
Enzyme
|
1.1E-02 |
0.488 |
0.731 |
ACVR1 |
Q04771
|
activin A receptor type 1
|
Kinase
|
0.33 |
0.535 |
0.731 |